Skip Navigation
Skip to contents

JPMPH : Journal of Preventive Medicine and Public Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
3 "Percutaneous coronary intervention"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
The Busan Regional CardioCerebroVascular Center Project’s Experience Over a Decade in the Treatment of ST-segment Elevation Myocardial Infarction
Kyunghee Lim, Hyeyeon Moon, Jong Sung Park, Young-Rak Cho, Kyungil Park, Tae-Ho Park, Moo-Hyun Kim, Young-Dae Kim
J Prev Med Public Health. 2022;55(4):351-359.   Published online June 24, 2022
DOI: https://doi.org/10.3961/jpmph.22.071
  • 2,466 View
  • 87 Download
  • 1 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Objectives
The Regional CardioCerebroVascular Center (RCCVC) project was initiated to improve clinical outcomes for patients with acute myocardial infarction or stroke in non-capital areas of Korea. The purpose of this study was to evaluate the outcomes and issues identified by the Busan RCCVC project in the treatment of ST-segment elevation myocardial infarction (STEMI).
Methods
Among the patients who were registered in the Korean Registry of Acute Myocardial Infarction for the RCCVC project between 2007 and 2019, those who underwent percutaneous coronary intervention (PCI) for STEMI at the Busan RCCVC were selected, and their medical data were compared with a historical cohort.
Results
In total, 1161 patients were selected for the analysis. Ten years after the implementation of the Busan RCCVC project, the median door-to-balloon time was reduced from 86 (interquartile range [IQR], 64-116) to 54 (IQR, 44-61) minutes, and the median symptom-to-balloon time was reduced from 256 (IQR, 180-407) to 189 (IQR, 118-305) minutes (p<0.001). Inversely, the false-positive PCI team activation rate increased from 0.6% to 21.4% (p<0.001). However, the 1-year cardiovascular death and major adverse cardiac event rates did not change. Even after 10 years, approximately 75% of the patients had a symptom-to-balloon time over 120 minutes, and approximately 50% of the patients underwent inter-hospital transfer for primary PCI.
Conclusions
A decade after the implementation of the Busan RCCVC project, although time parameters for early reperfusion therapy for STEMI improved, at the cost of an increased false-positive PCI team activation rate, survival outcomes were unchanged.
Summary
Korean summary
이번 연구에서는 부산권역심뇌혈관질환센터사업 시작 후 10여년간의 ST분절상습심근경색 환자 치료성적의 변화를 살펴보았다. 사업 시작 후 관상동맥중재시술팀의 위양성소집률이 크게 증가한 대신 ST분절상승심근경색 환자의 조기재관류 치료의 시간지표는 의미 있게 개선되었다. 그러나 생존지표는 사업 시작 전과 비교해 차이가 없었는데 중재시술이 불가능한 병원을 경우하는 사례가 많아 골든타임 이내에 조기 재관류치료를 받은 환자의 비율이 전체 환자의 1/4에 불과한 것이 그 원인으로 보인다.

Citations

Citations to this article as recorded by  
  • Relevance Index Regional Variation by Each Disease and Its Essential Medical Field: A Retrospective Data Analysis From 2016-2020 in Korea
    Young-Eun Kim, Jeehee Pyo, Haneul Lee, HyeRan Jeong, Young-Kwon Park, Jeong-Wook Seo, Minsu Ock, Seok-Jun Yoon
    Journal of Korean Medical Science.2023;[Epub]     CrossRef
The Prevalence of Cardiovascular Disease Risk Factors and the Framingham Risk Score in Patients Undergoing Percutaneous Intervention Over the Last 17 Years by Gender: Time-trend Analysis From the Mayo Clinic PCI Registry
Moo-Sik Lee, Andreas J. Flammer, Hyun-Soo Kim, Jee-Young Hong, Jing Li, Ryan J. Lennon, Amir Lerman
J Prev Med Public Health. 2014;47(4):216-229.   Published online July 31, 2014
DOI: https://doi.org/10.3961/jpmph.2014.47.4.216
  • 13,456 View
  • 108 Download
  • 14 Crossref
AbstractAbstract PDF
Objectives
This study aims to investigate trends of cardiovascular disease (CVD) risk factor profiles over 17 years in percutaneous coronary intervention (PCI) patients at the Mayo Clinic. Methods: We performed a time-trend analysis within the Mayo Clinic PCI Registry from 1994 to 2010. Results were the incidence and prevalence of CVD risk factors as estimate by the Framingham risk score. Results: Between 1994 and 2010, 25 519 patients underwent a PCI. During the time assessed, the mean age at PCI became older, but the gender distribution did not change. A significant trend towards higher body mass index and more prevalent hypercholesterolemia, hypertension, and diabetes was found over time. The prevalence of current smokers remained unchanged. The prevalence of ever-smokers decreased among males, but increased among females. However, overall CVD risk according to the Framingham risk score (FRS) and 10-year CVD risk significantly decreased. The use of most of medications elevated from 1994 to 2010, except for β-blockers and angiotensin converting enzyme inhibitors decreased after 2007 and 2006 in both baseline and discharge, respectively. Conclusions: Most of the major risk factors improved and the FRS and 10-year CVD risk declined in this population of PCI patients. However, obesity, history of hypercholesterolemia, hypertension, diabetes, and medication use increased substantially. Improvements to blood pressure and lipid profile management because of medication use may have influenced the positive trends.
Summary

Citations

Citations to this article as recorded by  
  • Can conventional cardiovascular risk prediction models be improved by nuclear magnetic resonance (NMR) metabolomic signatures?
    Remya Sudevan
    European Journal of Preventive Cardiology.2023; 30(3): 241.     CrossRef
  • Worse outcomes of ACS patients without versus with traditional cardiovascular risk factors
    Arthur Shiyovich, Tal Ovdat, Robert Klempfner, Roy Beigel, Majdi Halabi, Avinoam Shiran, Keren Skalsky, Avital Porter, Katia Orvin, Ran Kornowski, Alon Eisen
    Journal of Cardiology.2022; 79(4): 515.     CrossRef
  • Heterogeneity of Treatment Effects for Intensive Blood Pressure Therapy by Individual Components of FRS: An Unsupervised Data-Driven Subgroup Analysis in SPRINT and ACCORD
    Yaqian Wu, Jianling Bai, Mingzhi Zhang, Fang Shao, Honggang Yi, Dongfang You, Yang Zhao
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Radial artery access is under‐utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI Registry
    Rebecca C. Chester, Syeda A. Mina, Bradley Lewis, Nan Zhang, Richard Butterfield, Eric H. Yang
    Catheterization and Cardiovascular Interventions.2020; 95(4): 675.     CrossRef
  • Temporal trends of patients with acute coronary syndrome and multi-vessel coronary artery disease - from the ACSIS registry
    Arthur Shiyovich, Nir Shlomo, Tal Cohen, Zaza Iakobishvili, Ran Kornowski, Alon Eisen
    International Journal of Cardiology.2020; 304: 8.     CrossRef
  • Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: the Fremantle Diabetes Study Phase II
    Jocelyn J. Drinkwater, Timothy M. E. Davis, Valentina Hellbusch, Angus W. Turner, David G. Bruce, Wendy A. Davis
    Cardiovascular Diabetology.2020;[Epub]     CrossRef
  • Trends of Cardiovascular Risk Factors in Patients With Acute Myocardial Infarction: Soroka Acute Myocardial Infarction II (SAMI II) Project
    Ygal Plakht, Abeer Abu Eid, Harel Gilutz, Arthur Shiyovich
    Angiology.2019; 70(6): 530.     CrossRef
  • Sedentary lifestyle and Framingham risk scores: a population-based study in Riyadh city, Saudi Arabia
    AlJohara M. AlQuaiz, Amna Rehana Siddiqui, Ambreen Kazi, Mohammad Ali Batais, Ali M. Al-Hazmi
    BMC Cardiovascular Disorders.2019;[Epub]     CrossRef
  • Use of Global Risk Score for Cardiovascular Evaluation of Rural Workers in Southern Brazil
    Marta Regina Cezar-Vaz, Clarice Alves Bonow, Marlise Capa Verde Almeida de Mello, Daiani Modernel Xavier, Jordana Cezar Vaz, Maria Denise Schimith
    The Scientific World Journal.2018; 2018: 1.     CrossRef
  • 12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
    SeyedHossein Rabani, Mahsa Sardarinia, Samaneh Akbarpour, Fereidoun Azizi, Davood Khalili, Farzad Hadaegh, Katriina Aalto-Setala
    PLOS ONE.2018; 13(5): e0195543.     CrossRef
  • Cardiovascular risk factors in Middle Eastern patients undergoing percutaneous coronary intervention: Results from the first Jordanian percutaneous coronary intervention study
    Ayman J. Hammoudeh, Imad A. Alhaddad, Yousef Khader, Ramzi Tabbalat, Eyas Al-Mousa, Akram Saleh, Mohamad Jarrah, Assem Nammas, Mahmoud Izraiq
    Journal of the Saudi Heart Association.2017; 29(3): 195.     CrossRef
  • Changing Trends of Atherosclerotic Risk Factors Among Patients With Acute Myocardial Infarction and Acute Ischemic Stroke
    Shikhar Agarwal, Karan Sud, Badal Thakkar, Venu Menon, Wael A. Jaber, Samir R. Kapadia
    The American Journal of Cardiology.2017; 119(10): 1532.     CrossRef
  • Cardiovascular manifestations of renovascular hypertension in diabetic mice
    Sonu Kashyap, Sean Engel, Mazen Osman, Yousif Al-Saiegh, Asarn Wongjarupong, Joseph P. Grande
    PeerJ.2016; 4: e1736.     CrossRef
  • Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents
    Anna Franzone, Thomas Pilgrim, Dik Heg, Marco Roffi, David Tüller, André Vuilliomenet, Olivier Muller, Stéphane Cook, Daniel Weilenmann, Christoph Kaiser, Peiman Jamshidi, Lorenz Räber, Stefan Stortecky, Peter Wenaweser, Peter Jüni, Stephan Windecker
    Circulation: Cardiovascular Interventions.2015;[Epub]     CrossRef
English Abstract
A Comparative Study on Comorbidity Measurements with Lookback Period using Health Insurance Database: Focused on Patients Who Underwent Percutaneous Coronary Intervention.
Kyoung Hoon Kim, Lee Su Ahn
J Prev Med Public Health. 2009;42(4):267-273.
DOI: https://doi.org/10.3961/jpmph.2009.42.4.267
  • 5,214 View
  • 107 Download
  • 13 Crossref
AbstractAbstract PDF
OBJECTIVES
To compare the performance of three comorbidity measurements (Charlson comorbidity index, Elixhauser's comorbidity and comorbidity selection) with the effect of different comorbidity lookback periods when predicting in-hospital mortality for patients who underwent percutaneous coronary intervention. METHODS: This was a retrospective study on patients aged 40 years and older who underwent percutaneous coronary intervention. To distinguish comorbidity from complications, the records of diagnosis were drawn from the National Health Insurance Database excluding diagnosis that admitted to the hospital. C-statistic values were used as measures for in comparing the predictability of comorbidity measures with lookback period, and a bootstrapping procedure with 1,000 replications was done to determine approximate 95% confidence interval. RESULTS: Of the 61,815 patients included in this study, the mean age was 63.3 years (standard deviation: +/-10.2) and 64.8% of the population was male. Among them, 1,598 (2.6%) had died in hospital. While the predictive ability of the Elixhauser s comorbidity and comorbidity selection was better than that of the Charlson comorbidity index, there was no significant difference among the three comorbidity measurements. Although the prevalence of comorbidity increased in 3 years of lookback periods, there was no significant improvement compared to 1 year of a lookback period. CONCLUSIONS: In a health outcome study for patients who underwent percutaneous coronary intervention using National Health Insurance Database, the Charlson comorbidity index was easy to apply without significant difference in predictability compared to the other methods. The one year of observation period was adequate to adjust the comorbidity. Further work to select adequate comorbidity measurements and lookback periods on other diseases and procedures are needed.
Summary

Citations

Citations to this article as recorded by  
  • Adjusting for Confounders in Outcome Studies Using the Korea National Health Insurance Claim Database: A Review of Methods and Applications
    Seung Jin Han, Kyoung Hoon Kim
    Journal of Preventive Medicine and Public Health.2024; 57(1): 1.     CrossRef
  • High‐Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population‐Based Cohort Study
    Sungho Bea, In‐Sun Oh, Ju Hwan Kim, Dong Hyun Sinn, Yoosoo Chang, Seungho Ryu, Ju‐Young Shin
    Journal of the American Heart Association.2023;[Epub]     CrossRef
  • Impact of comorbidity assessment methods to predict non-cancer mortality risk in cancer patients: a retrospective observational study using the National Health Insurance Service claims-based data in Korea
    Sanghee Lee, Yoon Jung Chang, Hyunsoon Cho
    BMC Medical Research Methodology.2021;[Epub]     CrossRef
  • Evaluating the impact of covariate lookback times on performance of patient-level prediction models
    Jill Hardin, Jenna M. Reps
    BMC Medical Research Methodology.2021;[Epub]     CrossRef
  • Comorbidity and cervical cancer survival of Indigenous and non-Indigenous Australian women: A semi-national registry-based cohort study (2003-2012)
    Abbey Diaz, Peter D. Baade, Patricia C. Valery, Lisa J. Whop, Suzanne P. Moore, Joan Cunningham, Gail Garvey, Julia M. L. Brotherton, Dianne L. O’Connell, Karen Canfell, Diana Sarfati, David Roder, Elizabeth Buckley, John R. Condon, Stéphanie Filleur
    PLOS ONE.2018; 13(5): e0196764.     CrossRef
  • Comorbidity Adjustment in Health Insurance Claim Database
    Kyoung Hoon Kim
    Health Policy and Management.2016; 26(1): 71.     CrossRef
  • The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access
    Lorenzo Azzalini, Kunle Tosin, Malorie Chabot-Blanchet, Robert Avram, Hung Q. Ly, Benoit Gaudet, Richard Gallo, Serge Doucet, Jean-François Tanguay, Réda Ibrahim, Jean C. Grégoire, Jacques Crépeau, Raoul Bonan, Pierre de Guise, Mohamed Nosair, Jean-Franço
    JACC: Cardiovascular Interventions.2015; 8(14): 1854.     CrossRef
  • A Convergence Study in the Severity-adjusted Mortality Ratio on inpatients with multiple chronic conditions
    Young-Suk Seo, Sung-Hong Kang
    Journal of Digital Convergence.2015; 13(12): 245.     CrossRef
  • Development and validation of comorbidity index in South Korea
    S.-R. Kil, S.-I. Lee, Y.-H. Khang, M.-S. Lee, H.-J. Kim, S.-O. Kim, M.-W. Jo
    International Journal for Quality in Health Care.2012; 24(4): 391.     CrossRef
  • Development of Mortality Model of Severity-Adjustment Method of AMI Patients
    Ji-Hye Lim, Mun-Hee Nam
    Journal of the Korea Academia-Industrial cooperation Society.2012; 13(6): 2672.     CrossRef
  • Use of hospitalisation history (lookback) to determine prevalence of chronic diseases: impact on modelling of risk factors for haemorrhage in pregnancy
    Jian Sheng Chen, Christine L Roberts, Judy M Simpson, Jane B Ford
    BMC Medical Research Methodology.2011;[Epub]     CrossRef
  • The Impact of Medicaid Expansion to include population with low income on the preventable hospitalizations
    Hyun-Chul Shin, Se-Ra Kim
    Korean Journal of Health Policy and Administration.2010; 20(1): 87.     CrossRef
  • Comparative Study on Three Algorithms of the ICD-10 Charlson Comorbidity Index with Myocardial Infarction Patients
    Kyoung Hoon Kim
    Journal of Preventive Medicine and Public Health.2010; 43(1): 42.     CrossRef

JPMPH : Journal of Preventive Medicine and Public Health